Nancy Lynn Snyderman MD - 31 May 2025 Form 4 Insider Report for Alkermes plc. (ALKS)

Role
Director
Signature
/s/ Shantale Greenson, attorney-in-fact for Nancy Snyderman
Issuer symbol
ALKS
Transactions as of
31 May 2025
Net transactions value
-$58,894
Form type
4
Filing time
02 Jun 2025, 16:32:50 UTC
Previous filing
23 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
snyderman nancy lynn MD Director CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN /s/ Shantale Greenson, attorney-in-fact for Nancy Snyderman 02 Jun 2025 0001675198

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALKS Ordinary Shares Options Exercise +8,013 +173% 12,652 31 May 2025 Direct F1
transaction ALKS Ordinary Shares Tax liability $58,894 -1,924 -15% $30.61 10,728 31 May 2025 Direct
holding ALKS Ordinary Shares 20,783 31 May 2025 By the Snyderman Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALKS Restricted Stock Unit Award Options Exercise -8,013 -100% 0 31 May 2025 Ordinary Shares 8,013 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one ordinary share.
F2 Shares are held by the Nancy Lynn Snyderman Revocable Trust (the "Snyderman Trust"), of which the reporting person is both the sole trustee and sole beneficiary.
F3 This award is fully vested in accordance with its terms.